Navigation Links
Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Company's Anthrax Therapeutic
Date:9/25/2007

PINE BROOK, N.J., Sept. 25 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a privately held biopharmaceutical company developing antibody-based therapies for the treatment of life-threatening infectious diseases, today announced it has been awarded a contract for $12 million for advanced development of Anthim(TM), the company's late-stage anthrax therapeutic. This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Disease, National Institutes of Health and the Biomedical Advanced Research and Development Authority, Department of Health and Human Services, under Contract No. HHSN272200700035C. To date, Elusys has received more than $32 million from NIAID/BARDA and the Department of Defense in support of Anthim and the company's Heteropolymer Antibody(TM) technology.

Elizabeth Posillico, Ph.D., President and Chief Executive Officer of Elusys, commented on the award, "Elusys is encouraged by the continued support from the U.S. Government and we look forward to extending our collaboration with NIAID/BARDA. We are confident that Elusys has developed a highly effective and valuable anthrax therapeutic for procurement under Project BioShield for addition to the U.S. Government's Strategic National Stockpile."

Dr. Posillico continued, "Inhalation of anthrax spores rapidly leads to death if patients are not treated immediately with specific antibiotics. Typically, victims of inhalation anthrax experience only vague symptoms until it is too late, when they are in toxemia, leaving antibiotics largely ineffective. Anthrax vaccines are also ineffective unless victims are immunized well in advance of exposure. Anthim represents a 'just in time anthrax therapeutic,' that in relevant models has demonstrated complete protection against an anthrax spore challenge with a single prophylactic dose, and has shown significant protection when administered up to two days after a lethal spore challenge,
'/>"/>

SOURCE Elusys Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pelosi: Bush Veto of Stem Cell Bill Says No to the Hopes of Million of Families Across America
2. Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million Annually
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
5. Phase III Clinical Trial with 4-Month Long-Acting Formulation of Triptorelin: Ipsen Decides Not to Perform Further Administration
6. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
7. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
8. Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical Trial Data
9. MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
10. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
11. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 3, 2015 ReportsnReports.com adds ... with 2020 forecasts as well as Global Medical ... devices intelligence collection of its library. ... 2020 forecasts spread across 164 pages, talking about ... and figures is now available at http://www.reportsnreports.com/reports/407046-global-medical-simulation-industry-report-2015.html ...
(Date:8/3/2015)... , Aug. 3, 2015  Depomed, Inc. (NASDAQ: ... on Horizon Pharma plc,s (NASDAQ: HZNP ) ("Horizon") ... of Directors ("Depomed Board") set a record date to ... The Depomed Board will review the ... is received today and contains the information required under ...
(Date:8/3/2015)... , Aug. 3, 2015  Dr. Cal ... Orthopaedic & Spine Center today, providing patients ... their chronic pain through psychological counseling and treatment ... a Fellowship-trained, certified medical psychologist with an extensive ... vast experience ranges from assessment and treatment of ...
Breaking Medicine Technology:Medical Simulation Market to see 14% CAGR to 2019 2Medical Simulation Market to see 14% CAGR to 2019 3Medical Simulation Market to see 14% CAGR to 2019 4Medical Simulation Market to see 14% CAGR to 2019 5Medical Simulation Market to see 14% CAGR to 2019 6Depomed Comments on Horizon Pharma Announcement 2Depomed Comments on Horizon Pharma Announcement 3Depomed Comments on Horizon Pharma Announcement 4Depomed Comments on Horizon Pharma Announcement 5Depomed Comments on Horizon Pharma Announcement 6Orthopaedic & Spine Center Introduces New Pain Psychologist 2
... June 2, 2011 Craneware, Inc., the market ... new multi-year agreement today with Kingman Regional Medical ... AZ. Recognized as one of the nation,s five ... Center will add Craneware InSight Denials® to the ...
... 2011 Syndax Pharmaceuticals, a clinical-stage epigenetics oncology ... Patent and Trademark Office of Patent Application Serial ... B."   This follows the UK issuance which ... the extensive patent estate. The patent ...
Cached Medicine Technology:Kingman Adds Craneware Revenue Integrity Solution - InSight Denials® 2Kingman Adds Craneware Revenue Integrity Solution - InSight Denials® 3Kingman Adds Craneware Revenue Integrity Solution - InSight Denials® 4Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 2Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 3
(Date:8/4/2015)... ... August 04, 2015 , ... Isabel Healthcare and ... Symptom Checker available to all users of the KHIN personal health record, MyKSHealtheRecords.org. ... in an easy, intuitive method, provides access to material on possible conditions and ...
(Date:8/3/2015)... (PRWEB) , ... August 04, 2015 , ... While the pace of the economic recovery ... States has clearly been on a growth trajectory for the last six years. Unemployment has ... and is trending at a 3.5 percent growth rate in 2014, the U.S. stock market ...
(Date:8/3/2015)... TX (PRWEB) , ... August 04, 2015 , ... ... convenient and affordable online CE courses for rehabilitation professionals, HomeCEUConnection.com today announced extra ... professionals in Florida can now take advantage of big savings on Physical ...
(Date:8/3/2015)... ... ... Master offers the most affordable web design and SEO services for start up companies. ... their dollar. Every company that is starting out needs to be online in this ... does a start up need to be online, they need to physically be present and ...
(Date:8/3/2015)... , ... August 03, 2015 , ... Sutter Health’s California ... operating officer (COO) at CPMC. Hamila will start in her role effective immediately and ... , Kownacki has worked at CPMC and Sutter Health for about 15 years, including ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 2Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 2Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 4Health News:Elite Online CE Provider Offers Discounted Flexible Packages to Meet Florida Physical Therapy Continuing Education Requirements 2Health News:Web SEO Master, a division of SH Web Design & SH Web Commerce, Inc. begins offering Web Design and SEO Services for Start Up Companies located in Indianapolis, Indiana 2Health News:Web SEO Master, a division of SH Web Design & SH Web Commerce, Inc. begins offering Web Design and SEO Services for Start Up Companies located in Indianapolis, Indiana 3Health News:Hamila Kownacki, RN Appointed as New Chief Operating Officer at CPMC 2
... new study by specialists at the Johns Hopkins Children’s ... inner-city children with chronic asthma //gets enough medicine to ... reported in December's Pediatrics, are disturbing, the researchers say, ... 'rescue' drugs after an asthma attack strikes and to ...
... The American Dental association announced on the 9th of November, ... preparation of infant formulation. // ,The dentists are concerned ... might be disastrous as instead of protecting teeth it might ... lead to weakened bones and even bone cancer boys. ...
... and Improvement suggested that some patients should be cared for ... them in the hospital wards. ,The draft ... and Emergency (A&E) departments that leads to hospital admissions and ... admitted in hospital wards. ,Home treatments ...
... in a gene known as SOS1 account for many ... //disorder which occurs in one in 1,000-2,500 live births. ... learning disabilities, as well as heart problems and predisposition ... School-Partners Healthcare Center for Genetics and Genomics (HPCGG) and ...
... of dubious consolation, nineteen persons infected with AIDS will ... most moneyed lawsuit//. This money should provide some relief ... them are living in poverty. ,Fifteen persons were ... at a provincial hospital of northern China in 2004. ...
... programme has been working effectively and the same has ... UNAIDS has not informed the Government about any award ... prevention amongst the services. ,The incidence of ... 2005 was 0.028%. ,No disciplinary action is ...
Cached Medicine News:Health News:City Kids With Asthma Lose Out on Preventive Treatment 2Health News:Study Uncovers Mutation Responsible for Noonan Syndrome 2
The CA method used on the Dade Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of calcium in serum....
For the quantitative in vitro determination of Total Protein in serum and plasma...
The LDH method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of lactate dehydrogenase activity in serum or plasma...
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum....
Medicine Products: